General Information
Revision date
2021-04-09
Product name
Atorvastatin Formulation
CAS No.
134523-03-8
1.2.1 Relevant identified uses
Pharmaceutical
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H373, H412
Hazard statements
Code
Statements
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
CLP CLASSIFICATION
Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure. Long-term (chronic) aquatic hazard, Cat- H412: Harmful to aquatic life with long lasting ef- egory 3 fects.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Warning
Hazard statements
H373 May cause damage to organs through prolonged or repeated exposure. H412 Harmful to aquatic life with long lasting effects.
Prevention
P260 Do not breathe dust. P273 Avoid release to the environment.
Response
P314 Get medical advice/ attention if you feel unwell.
Hazardous Ingredients
Atorvastatin
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means.
